Percutaneous Coronary Intervention, Diabetes Mellitus, and Death

Journal of the American College of Cardiology

Volumn 55, Issue 11, 2010, Pages 1076-1079

  Dauerman, Harold L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

coronary artery bypass grafting; diabetes mellitus; percutaneous coronary intervention

Indexed keywords

CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; EDITORIAL; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RISK FACTOR; STROKE; SURVIVAL RATE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HUMANS;

EID: 77649229104     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.056     Document Type: Editorial

References (20)

1. Banning A.P., Westaby S., Morice M.-C., et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 55 (2010) 1067-1075
2. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
3. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96 (1997) 1761-1769
4. Hlatky M.A., Boothroyd D.B., Bravata D.M., et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373 (2009) 1190-1197
5. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 (1996) 217-225
6. Novack V., Tsyvine D., Cohen D.J., et al. Multivessel drug-eluting stenting and impact of diabetes mellitus-a report from the EVENT registry. Catheter Cardiovasc Interv 73 (2009) 874-880
7. Frye R.L., August P., Brooks M.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360 (2009) 2503-2515
8. Mueller H.S., Cohen L.S., Braunwald E., et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis In Myocardial Infarction (TIMI) trial, phase II. Circulation 85 (1992) 1254-1264
9. Feit F., Brooks M.M., Sopko G., et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation 101 (2000) 2795-2802
10. U.S. National Library of Medicine. Clinical Alert: Bypass Over Angioplasty for Patients With Diabetes, National Heart, Lung, and Blood Institute (NHLBI), September 21, 1995. http://www.nlm.nih.gov/databases/alerts/bypass_diabetes.html Accessed September 2, 2009
11. The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
12. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49 (2007) 1600-1606
13. Aggarwal A., Schneider D.J., Sobel B.E., and Dauerman H.L. Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting. Am J Cardiol 92 (2003) 924-929
14. Daemen J., Kuck K.H., Macaya C., et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. J Am Coll Cardiol 52 (2008) 1957-1967
15. Kim L.J., King III S.B., Kent K., et al. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial. J Am Coll Cardiol Intv 2 (2009) 384-392
16. Gogo Jr. P.B., Dauerman H.L., Mulgund J., et al. Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). Am J Cardiol 99 (2007) 1222-1226
17. Detre K.M., Guo P., Holubkov R., et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99 (1999) 633-640
18. Lee T.T., Feinberg L., Baim D.S., et al. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials). Am J Cardiol 98 (2006) 718-721
19. Chacko R., Mulhearn M., Novack V., et al. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting. J Am Coll Cardiol Intv 2 (2009) 498-503
20. Farkouh M.E., Dangas G., Leon M.B., et al. Design of the Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial. Am Heart J 155 (2008) 215-223